Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience.

Register now to attend CX 2023! Take a look at the upcoming podium first highlights below.

CX 2023 – PODIUM FIRST:alt_textPodium First: Primary endpoint results of the STRIDE trial on thrombectomy for acute limb ischemia

  • When: Tuesday 25 April, 10:30 – 10:35
  • Where: Kensington 1 / Livestream 1
  • Who: Sean Lyden

Bioresorbable Drug-Coated Stents Session

  • When: Tuesday 25 April 14:40 – 15:20
  • Where: Kensington 1 / Livestream 1
  • Who: Ramon Varcoe, Michel Bosiers, Andrew Holden

“We’ve got a dedicated session on bioabsorbable scaffolds – that’s been the holy grail for scaffolds for a number of years. In other words, we get the acute support of a scaffold or stent, but we don’t get the long-term problems with it.”
alt_textPodium First: Statin treatment after aortic repair saves lives, but dose doesn’t matter

  • When: Wednesday 26 April, 09:05 – 09:10
  • Where: Kensington 1 / Livestream 1
  • Who: Kevin Mani
alt_textPodium First: IN.PACT AV Access trial – 3 year subanalysis data 

  • When: Tuesday 25 April, 11:00 – 11:05
  • Where: Admiral / Livestream 3
  • Who: Andrew Holden

“I’ve been privileged to present data over the years at Charing Cross of the most powerful randomised control trial of drug coated balloons and AV access – the IN.PACT AV trial published in the New England Journal of Medicine.”

Podium First: A new kind of graft

  • When: Tuesday 25 April, 12:30 – 12:35
  • Where: Admiral / Livestream 3
  • Who: Frans Moll